Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease.

ABSTRACT:

Background

COVID-19 survivors report residual lung abnormalities after discharge from the hospital. The aim of this study was to identify biomarkers in serum and induced sputum samples from patients after hospitalization for COVID-19.

Methods

Patients admitted to hospitals in Spain with laboratory-confirmed COVID-19 were recruited for this study. SARS-CoV-2-infected patients were divided into groups with mild/moderate and severe disease according to the severity of their symptoms during hospitalization. Levels of 92 biomarkers were measured in serum and induced sputum samples.

Results

A total of 108 patients (46.2% severe cases) were included in this study. The median number of days after the onset of symptoms was 104. A significant difference was observed in diffusin

SUBMITTER: Blanco JR 

PROVIDER: S-EPMC8908919 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature